Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

June 30, 2007

Study Completion Date

December 31, 2007

Conditions
Myelodysplastic Syndrome
Interventions
DRUG

Antithymocyte globulin

DRUG

Cyclosporine

Trial Locations (11)

Unknown

Hospital de Cabueñes, Asturias

Hospital germans Trias i Pujol, Badalona

Hospital de Basurto, Bilbao

Hospital Ntra Sra del Rossell, Cartagena

Hospital Materno Infantil de Las Palmas, Las Palmas de Gran Canaria

Hospital Virgen de la Victoria, Málaga

Hospital Morales Messeguer, Murcia

Hospital de Navarra, Pamplona

Hospital Arnau de Vilanova, Valencia

Hospital Dr Pesset, Valencia

Hospital Clinico Universitario, Zaragoza

All Listed Sponsors
lead

PETHEMA Foundation

OTHER

NCT00488436 - Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter